Abstract
Re-emergence of infectious diseases caused by mycobacteria as well as the emergence of multiresistant strains of Mycobacterium has promoted the research on the use of beta-lactames in the treatment of such diseases. Mycobacteria produce beta-lactamases: M. tuberculosis produces a wide-spectrum beta-lactamase whose behaviour mimicks those of Gram-negative bacteria. M. kansasii produces also beta-lactamase which can be inhibited by clavulanic acid. An overview on beta-lactamases from both species is reported.
| Original language | English |
|---|---|
| Pages (from-to) | 331-336 |
| Journal | Microbiologia SEM |
| Volume | 13 |
| Issue number | 3 |
| Publication status | Published - 1 Jan 1997 |
